Governing Body Assurance Framework
|
|
- Katrina Rich
- 5 years ago
- Views:
Transcription
1 Agenda Item: 6 Paper Ref: 6.1 Governing Body Assurance Framework MEETING: NHS Enfield Clinical Commissioning Group Governing Body DATE: 22 May 2013 TITLE: LEAD BOARD MEMBER: Governing Body Assurance Framework Aimee Fairbairns, Quality and Integrated Governance AUTHOR: CONTACT DETAILS: Bridget Pratt, Head of Governance & Risk Aimee.Fairbairns@nclondon.nhs.uk SUMMARY: The 2013/2014 Governing Body Assurance Framework (GBAF) will set out the key s to achieving the CCG s strategic objectives and priorities. They include s associated with quality and safety, maximising productivity, efficiency and cost effectiveness. The GBAF (also known as the Board Assurance Framework (BAF)) is an important document for providing external assurance (for example to NHS England, Audit and the public) that Enfield CCG is sighted on its s and has a robust system of internal control. The Governing Body is only properly able to fulfil responsibilities through an understanding of the principle s facing the organisation. Assurance Framework Process The Assurance Framework is populated and updated through an escalation process described in Enfield CCG s Risk Management Strategy. The Assurance Framework provides the Governing Body with all key s from 1 st April It incorporates open s from the 2012/2013 Assurance Framework which was part of Enfield CCG s governance and management process as a shadow organisation. The Assurance Framework enables a focused view on the challenges to the delivery of the CCG s key objectives agreed in 2012/2013. Corporate Objectives from 2012/13 and their 1
2 review will form part of the organisational development process for 2013/14. Until the 2013/14 corporate objectives have been developed, the 12/13 objectives remain in place. There has been a robust review of significant s by Senior Responsible Officers and Risk Leads. Open s from the 2012/2013 Assurance Framework have been reviewed and obsolete s have been redefined. Risks that have been fully implemented have been closed and archived. New s impacting on the CCGs corporate objectives have been incorporated and labelled as new s in the document. Enfield CCG continues to work with Public Health to identify and mitigate s relating to the Joint Strategic Needs Assessment and the Health & Wellbeing Strategy. This will feed into the CCG s management and monitoring process in 2013/2014. SUPPORTING PAPERS: The Assurance Framework is relevant to the CCG Commissioning Strategic Plan, Ope Plan, Corporate and Directorate Risk Registers. RECOMMENDED ACTION: The Governing Body is asked to note the Assurance Framework which has been developed from the 12/13 Assurance Framework. A full review of the 2013/2014 Assurance Framework will be undertaken at the June Audit Committee with further update to the July Governing Body Meeting. In line with the Enfield CCG Risk Management Strategy, the Assurance Framework will form part of regular reporting to the Executive Committee, Audit Committee and Governing Body. Objective(s) / Plans supported by this paper: Constitution The GBAF applies to all plans related to services commissioned by the CCG Patient & Public Involvement (PPI): Enfield CCG aims to involve patients and the public in implementing its corporate objectives. Equality Impact Analysis: This is conducted in line with commissioning intentions. Risks: As cited on the GBAF, Corporate and Directorate Risk Registers Resource Implications: Resources implications associated to Assurance Framework s are considered and specified as part of the review process Audit Trail: The 2012/2013 GBAF went through rigorous review at the Audit Committee, CCG Executive and Quality & Safety Committee and a similar process will apply in 2013/2014. Next steps: Develop and strengthen the CCGs 13/14 corporate objectives via the organisational development programme. 2
3 Audit Committee sign off of the Assurance Framework for the July Governing Body Meeting Implement the Datix electronic management software for monitoring and updating the Assurance Framework and Risk Registers. A programme of training will be rolled out for Risk Leads by the end of June Contents 1. Assurance Framework Document creation Corporate Objectives Governing Body Assurance Framework Risk Grading Matrix Appendix 1: How to interpret the Enfield CCG Board Assurance Framework
4 1. Assurance Framework The purpose of the Governing Body Assurance Framework (GBAF) is to: Identify the main s to achieving Enfield CCG s objectives, List and evaluate the mitigations in place to the reduce the likelihood or impact of the, Summarise the remedial or proposed actions that further mitigate the likelihood or impact of the. Summarise the controls, assurances and gaps relating to each main. The GBAF is an important document for providing external assurance (for example NHS England, Internal Audit and the public) that Enfield CCG is sighted on its s and has a robust system of internal control. The GBAF is populated and updated through an escalation process described in the Enfield CCG Integrated management framework. The scoring matrix to establish initial s is shown at section Document creation This document was populated from s identified from the following sources: Risk assessment of Enfield CCG objectives Collaboration on issues with CCGs in NCL and NECL The s were accumulated, filtered and reviewed by the Governance team with the Risk Owners and Leads to produce this Governing Body Assurance Framework. 4
5 3. Corporate Objectives In 2012 the Enfield CCG Governing Body agreed the following Corporate Objectives: 1. Enable the people of Enfield to live longer fuller lives by tackling the significant health inequalities that exist between communities 2. Provide children with the best start in life 3. Ensure the right care in the right place, first time 4. Deliver the greatest value for money for every NHS pound 5. Commission care in a way which delivers integration between health, primary, community and secondary care and social care services Corporate Objectives from 2012/13 and their review will form part of the organisational development process for 2013/14. Until the 2013/14 corporate objectives have been developed, the 12/13 objectives remain in place. 5
6 4.0. Full Governing Body Assurance Framework Corporate Objective 1: Enable the people of Enfield to live longer fuller lives by tackling the significant health inequalities that exist between communities. Risk No Executive Lead & Clinical Lead Initial Current Gaps Internal External Control Assurance Target CO1-01 Risk redefined from the 2012/2013 BAF Service Quality and Integrated & Medical Director There is a that the CCG will not be able to invest sufficiently in services to reduce inequalities if it does not deliver its financial savings. This could lead to a failure to improve life expectancy 4 x4 =16 - Finance Recovery & QIPP (FR&Q) Committee in place to oversee the allocation of resources. -Public Health Engagement with GPs. -PPE Committee overseeing equality -Executive lead in post with lead for equality. -Equality Strategy in place. -TOR, agendas and minutes of FR & Q Committee -Job description and objective of Executive lead -Equality reports -Committee and Governance structure. -The Governing body approved strategies. -Minutes of PPE Meetings -Equality Plan. -Health & Well Being Board (HWBB) Terms of Reference (TOR), agendas and minutes. -NHS England -Positive Patient & Public Engagement (PPE) feedback. 3 x 4 = 12 Links with Local Authority and voluntary / 3 rd sector to be strengthened. Evidence of relationships with key stakeholders. - Continue to work with the Health & Well Being Board. - Continue to work with Joint Commissioning Board. - Increase patient engagement through Patient Participation Group s (PPG s) and external events. - Appoint Patient Representative to Governing Body (GB). - Continue rigorous control of budgets through FR&Q Committee. 1 x 4= 4 Corporate Objective 2. Provide children with the best start in life There are currently no significant s against this objective 6
7 Corporate Objective 3: Ensure the right care in the right place, first time CO3-01 Risk redefined from the 2012/2013 BAF Barnet, Enfield & Haringey (BEH) Programme Director & Medical Director BEH Clinical Strategy Programme: There is a that the transfer of services may be affected by the commencement of a judicial review which could impact on the delivery of programme. 4 x 4= 16 -Strong governance arrangements in place across programme and within Trusts. -Full engagement and communication with stakeholders. -Issues resolved as raised through the implementation phase of the programme. Governing Body. - BEH Clinical Strategy Programme governance including Programme Board and SRO. 4x 4= 16 Develop joint indicators monitoring progress on primary care strategy. Fully meet the Independent Review Panel recommenda tions. - Joint indicators monitoring progress to be developed with stakeholders. - The IRP recommendations are progressing and will be fully met. The clinical case for change is strong. 3x4= 12 CO3-02 Risk redefined from the 2012/2013 BAF Service Quality and Integrated Governanc e & Medical Director Changes in the provider landscape which also includes the BEH Clinical Strategy could affect the Quality and Safety of patient care during transition. 4 x 4 = 16 -BEH Clinical Cabinet. -Clinical Quality Review Groups for each contract. -Quality and Safety Committee reporting. -Performance reporting through governance framework to the Governing Body. -Quality and Safety Committee. -Governing Body. -Clinical Cabinet. -BEH Programme Board. -Internal Audit. -Joint BEH CCG Gateway review. -NHS England external clinical assurance process 3 x 4 = 12 Enfield CCG Integrated Quality and Performanc e report in developmen t Full reporting against BEH quality metrics not yet fully established -Clinical Cabinet to receive quality report June Work with CSU to ensure report delivers to agreed timescales (June 2013). 2 x 4 = 8 New CO3-03 BEH MH Programme Director & Mental Health Clinical Lead There is a that the Trust Development Agency (TDA) will not authorise BEH MHT to proceed to FT Status which could impact on service, business continuity and prolonged period of uncertainty. 4x4-16 -Contribute to the TDA Gateway Review to ensure an accurate reflection of clinical practice is captured. -Work collaboratively with BEH on the implementation of an action plan arising from TDA recommendations. Governing Body TDA review 3 X 4=12 Implementa tion of action plan following TDA review Awaiting TDA review -Joint response with BEH once TDA review is completed. -Scrutiny of Governing Body. 3 X4=12 7
8 Corporate objective 4: Deliver the greatest value for money for every NHS pound Risk No. Executive Lead & Clinical Lead Initial (LxC=R R) Internal External Current Gaps Control Assurance Target CO4-01 Risk redefined from the 2012/2013 BAF Interim Strategy & Performance & CCG Chair The CCG is at of not complying with statutory responsibilities due to the lack of clarity on the arrangements in place for the following areas: -Health & Safety -Security -Infection Control -Mandatory training -Emergency Planning/business continuity plans -Complaints and IFRs This could result in legal challenge and adverse publicity or a serious incident. 3 x 5 = 15 - Commissioning Support Unit (CSU) has confirmed mandatory training is included in Service Level Agreement (SLA). Working with the CSU to clarify what is covered within SLA for: -Emergency Planning/business continuity plans -Complaints and IFRs -Where necessary, contingency management arrangements by senior managers, overseen by lead Director/s -Regular contracts and CSU meetings. -CCG management review of transferred functions and options to adapt structure to accommodate non-csu provided functions presented to Executive Group 08/05/13. -NHS England. -Internal & External Audit. 2 x 5 =10 -Confirmation received from the CCG that that the following areas are not included in the SLA: -Health & Safety -Security -Infection Control -Lack of clarity regarding specification of some CSU services and CCG decision lead roles due to early stage of development Services listed below are not part of the CSU core offer: Health & Safety Security Infection Control CSU service provides point of coordination and advice, not the full direct service: Occupational health Equality and Diversity Policies Legal Affairs/legal claims -Arrangements to be put in place following discussions with the CSU. -Chief Officer to decide on adaptations to structure within budget based on CCG management review of transferred functions with Chair and other Executive Group members. -Presentation of key changes to Governing Body. -Remuneration and Nomination Committee to consider any new very senior roles within its remit. 2 x 5 =10 8
9 Risk No. Executive Lead & Clinical Lead Initial (LxC=R R) Internal External Current Gaps Control Assurance Target New CO4-02 Interim Strategy & Performance & CCG Chair Risk of differing service scope expectations between CCG and CSU in first agreement year, due to the changing face of commissioning landscape. This may include business elements that are not yet in place / still to be set up affecting operational capability to deliver commissioning support services. 4 x 4 = 16 - CCG strategy and business plan. -Agreed SLA between CCG and CSU for core and additional services. -GB Agreed updated SLA with KPIs between CCG and CSU for core and additional services 22 January Quarterly SLA review meetings scheduled. - Annual SLA review and acceptance of in year variations to agreement scheduled. -CCG and CSU Collaborative working through issues identified in new commissioning requirements. -CCG Executive Committee. -Joint commissioning support delivery issues log reviewed 2 to 4 times per month by Interim DS&P and CSD. -System wide DoH and NHS England approval of NEL CSU Business Plans. -Internal Audit. 4 x 4 = 16 Confirmation of ope framework: service specifications, standard ope procedures and service line costings Service specifications, standard ope procedures and service line costing are in production - Confirmation by CSU of new ope framework. -Joint resolution of service offer delivery issues, including briefings on standard ope procedures and connectivity with CCG functions and decision leads. -Request new service requirements or amendments to services under current SLA with clear specification. 2 x 4 = 8 -Commissioning Support Director (CSD) management of inclusion of new service or amendment to service. 9
10 Risk No. Executive Lead & Clinical Lead Initial Internal External Current Gaps Control Assurance Target CO4-03 Risk redefine d from the 2012/20 13 BAF Finance & Commissio ning (DF&C) & Chair of the Finance & Recovery Committee Risk that the CCG will not achieve financial balance for the year 2013/2014. This could lead to: -Reduced ability to achieve all Corporate Objectives, -Negative media coverage and reduced public support for the CCG. 4 x 5 = 20 -Robust processes in place to ensure delivery of the financial outturn including the 2013/14 QIPP Plan. -Transformation Programme Group (TPG) in place and meeting every two weeks to ensure QIPP achievement and provider run rate reductions -Documented reporting process for the reporting of financial data to the Financial, Recovery & QIPP Committee. -Minutes of Transformation Programme Group. -Minutes of ECCG Governing Body demonstrate Board oversight. -Monitoring by NHS England. -Internal & External Audit Reports. 3 x 5 = 15 -Identify new opportunitie s for savings utilising external reviews e.g. PwC. -Improve data quality, which will better inform procurement proposals. -Continued reporting of Financial status to FR&Q Committee. -Audit Committee Scrutiny. 2 x 5= 10 Risk No Executive Lead & Clinical Lead Initial Internal External Current Gaps Control Assurance Target 10
11 Risk No Executive Lead & Clinical Lead Initial Internal External Current Gaps Control Assurance Target CO4-04 Risk redefined from the 2012/201 3 BAF Interim Strategy & Performan ce & CCG Chair - There is a that Enfield CCG may not discharge the 7 conditions on Authorisation set by NHS England if: The rectification plan not approved by NHS England. Milestone/s not met for planned discharge of conditions at June Authorisation Assurance Review with NHS England. Governance of collaboration agreements between CCGs is not sufficiently effective as assessed by NHS England. 4 x 5 =20 -Establishment of NHS Enfield CCG as a CCG on 6 March 2013 by NHS England with 7 Authorisation Conditions, including one legal direction (out of 119 criteria). -Rectification Plan submitted by deadline of 12/04/13m -Inclusion of Rectification Plan deliverables and milestones in Integrated Performance Reporting process.. -ECCG ope plan -Authorisation rectification plan deliverables and action on any variances included in Integrated Performance Reporting. -Executive Group Review. -Governing Body Reports. -Organisational Development Plan. NHS England 2 x 5 =10 -NHS England commentary of rectification plan not yet received. Due w/c 13/05/13. -NCL CCGs Collaboration Risk Sharing Agreement yet to be agreed by all CCGs. -Risk share agreement document approved by all NCL CCGs. -External review of Financial Recovery Plan (see Risk Register for Financial Recovery & QIPP. Delivery of actions against milestones set out in the Rectification Plan and also assurance review with NHS England in June x 5 = 5 share agreements between CCGs is not sufficiently effective as assessed against the Ope Plan and Financial Recovery Plan by NHS England. This may result in negative media coverage and reduced public opinion. -Organisational Development Plan to secure current and future leadership and management capabilities. 11
12 Risk No. Executive Lead & Clinical Lead Initial Internal External Current Gaps Control Assurance Target (LxC=R R) CO4-05 Risk redefi ned from the 2012/2 013 BAF Finance & Commissioning & Chair of Finance Recovery & QIPP Committee Insufficient QIPP Schemes may result to the CCG not meeting its 3 year QIPP plan (this is also linked with acute care contracts over performing). This could lead to: -Reduced ability to achieve all Corporate Objectives. -Negative media coverage and reduced public opinion. 5 x 5 =25 -QIPP plans are a key enabler for achieving future financial planning and balance. -Fortnightly QIPP Plan Steering / Transformation Programme Group (TPG) has been established to oversee development of 3 year financial plan and QIPP Schemes. -Financial Recovery Plan to identify weakness and to delivery. -Commissioning Strategic Plan to NCB. -Finance, Risk & QIPP Committee and GB overview and controls in place. -QIPP reporting to CCG. -Transformation Programme Office (TPO) performance monitoring reviews reporting to TPG. -Financial Recovery & QIPP Committee (FR&QP). -Review all QIPP plans for approval by CCG Governing Board. -Monitoring by NHS England. -Internal Audit Review Report. 2 x 5 = 10 -Review all QIPP plans for approval by CCG Governing Board Continued Review & performance monitoring connected with TPG and FR& Q Committee -CCG/GP Leadership & Engagement in programme to deliver QIPP. -Identification of further saving opportunities. -Cooperation and collaborative work with providers and CCGS in the development of health system wide plans. -Project Management Control. 1 x 5= 5 12
13 Risk No. Executive Lead & Clinical Lead Initial Internal External Current Gaps Control Assurance Target (LxC=R R) New s C04-06 Finance & Commissioning & Chair of Finance Recovery & QIPP Committee Transfer of Specialist commissioning to NHS England. There is a that the CCG s will be adversely affected by the impact of the transfer of Specialist Commissioning Services to NHS England which could impact on the CCG s financial position. Risk increased by additional reduction of 9m from CCG allocation 4x5 = 20 -CSU reconciliation of Specialist Commissioning baseline and impact by provider. -NHS England expectation is the impact on the CCG will be neutral following monthly reconciliation. -Finance Recovery and QIPP Committee. -CSU Contracts and Analytics Team review and control of Specialist Commissioning values. -External Audit -NHS England 3x5 = 20 Revised reconciliation being carried out by the CSU following 9m reduction in CCG allocation. Clarity of monthly reconciliation process and impact of month 6 review based on actual costs. Obtain confirmation of neutrality Complete reconciliation and assess Financial implications 30 th June (Completion of this action should result in a reduced target consequence score). Inform NHS England of implications and obtain confirmation of neutrality 30 th June x4 = 12 New C04-07 Finance & Commissioning & Chair of Finance Recovery & QIPP Committee Finalisation of 2013/14 SLA s with major providers. There is a to the CCG if SLA s with major Acute, Mental Health and community Providers are not finalised and signed which could impact on the CCG s financial position and performance delivery. 4x5 = 20 -Affordability analysis -CSU updates on progress on contractual negotiations -Report to GB -Weekly Contract Steering Group Meetings Simon to confirm if this exists. -Direct discussions between senior CCG executives and provider executives. Internal & External Audit 2x5 = 10 SLA to be finalised Report to GB Report to May GB on Current Status 30 th June x5 = 10 New C04-08 Finance & Commissioning & Chair of Finance Recovery & QIPP Committee Retrospective Continuing Care Claims. There is to the CCG if the cost of retrospective claims are not accurately assessed which could impact on the CCGs financial position. 4x5 = 20 CCG involvement in 2012/13 annual accounts process for NHS Enfield including 30% reserve proposed in 2012/13 results Finance, Recovery & QIPP Committee NHS England 2x5 = 10 None present at None present at Keep under review 2x5 = 10 13
14 Risk No. New C04-09 New C Executive Lead & Clinical Lead Interim Director of Performance & Strategy & Medical Director Finance & Commissioning & Medical Director Access to SUS National data system is only available to ECCG for PCT closedown purposes for 12/13. Enfield CCG is not able to access patient data from the SUS system until national agreement is determined. This may cause delays to schemes incurring financial to performance and contract monitoring and accessing information for Enfield Transformation Performance s: Acute Provider is unable to meet Constitution target for waiting times on referral to treatment, A&E and diagnostic waits resulting in individuals waiting beyond the national standard. Initial 4x5 = 20 4x5 = 20 -CSU Analytics working to resolve the issue -Consistent and continual communication between CCG and CSU. -Application of Information Governance advice and good practice resulting in suspension of CCG use of patient identifiable data. - Formal contracts in place with providers -Contract and Quality Review Group meeting structures in place. -Performance improvement plans in place from provider. Internal CCG Executive Regular exception reports and monthly monitoring performance reports External -NHS England -NHS Information Centre. -Information Commissioner -Internal Audit. -NHS England. -Internal Audit. Current 4x5 = 20 4x5 = 20 Gaps Control Lack of sufficient controls issue is National and requires DOH/Informat ion Centre action Detailed information requested from provider on a validation and demand and capacity modelling process to validate the current position Assurance No clear timescale for resolution Questions requesting more detailed information and explanation of how the Trust is providing assurance to its Trust Board -Continued dialogue with CSU Analytics. -Resolution requires national determination. -The Trust is undertaking a validation process and has been required to provide a recovery action plan. -Full impact is being assessed with the Trust supported by CSU and appropriate plans will be determined to minimise impact. Target (LxC=R R) 3x5 = 15 3x5 = 15 14
15 Risk No. New C Executive Lead & Clinical Lead Finance & Commissioning & Medical Director Barnet, Enfield & Haringey Mental Health Trust is unable to meet national target for increasing access to psychological therapies resulting in potential for an imbalance in demand/supply with increased waiting times and potential increased referrals to secondary services. Initial 4x5 = 20 Formal contracts in place with providers Internal Performance Reports External External review of service to determine an appropriate way forward. Current 4x5 = 20 Gaps Control Level of investment to be finalised Assurance Contract not agreed with provider for 13/14 and level of investment is yet to be confirmed -Level of investment to be confirmed. -Contract to be finalised. -External review to be completed to determine appropriate way forward expected timescale for review July. Corporate Objective 5: Commission care in a way which delivers integration between health, primary, community and secondary care and social care services Target (LxC=R R) 3x5 = 15 Risk No. Executiv e Lead & Clinical Lead Initial Current Gaps Internal External Control Assurance Target CO5-01 Redefined from the 2012/2013 BAF Chief Officer & Medical Director Primary Care Strategy: As the CCG no longer commissions Primary Care, there is a that some initiatives will be more complex to commission and the CCG will need additional support from NHS England & other bodies which may result in a potential delay in the implementation of the Primary Care Strategy 4x4= 16 -Medical Director and Primary Care Lead Networks Champions in place. -Project Delivery team now fully in place. -Oversight and direction by Primary Care Strategy Implementation. Board -Primary Care Strategy Board. -Monthly reporting to CCG Executive. -Health & Well Being Board. -Internal Audit Review. 3x4= 12 -Potential conflicts of interest may lead to lack of Clinical approval of improvement scheme. -Lack of capacity of health watch to provide a patient perspective. -Currently no peer review group established for Locally Enhanced Service (LES) approval. -Wider audit of adherence to the Conflict of Interest policy. -Wider audit of the Conflict of Interest Policy via internal audit. -Monthly reporting to CCG Board and Executive in implementation plan. 2x4= 8 15
16 Risk No. Executiv e Lead & Clinical Lead Initial Current Gaps Internal External Control Assurance Target New CO5-02 Chief Officer & Medical Director Primary Care Strategy: Poor GP engagement, coordination of relevant teams and lack of defined outcome measures may result in not achieving goals of the Primary Care Strategy through networking arrangements 4x4= 16 Workshops by GP Champions at Network Level have taken place -Primary Care Strategy Board -Monthly reporting to CCG Executive -Internal Audit Review 3x4= 12 Lack of awareness of GPs impacting on GP engagement and uptake of improvement schemes Lack of defined outcomes -Further workshops and planning sessions on GP involvement to be held. -Further clinical led focus groups on taking up new activities. 2x4= 8 New CO5-03 Chief Officer & Medical Director Risk that the budget allocated to Enfield for 2013/2014 will not be spent in full which could result in reduced capacity and expertise in delivering local health care with a consequential political impact 4x4= 16 Regular reporting budget -Primary Care Strategy Board. -Monthly reporting to CCG Executive. -Internal Review. Audit -Local Budget Reporting at CCG level. -Internal Audit Review 3x4= 12 Lack of early clarity in total budget allocation The approval process for new schemes (see MDR 006) -Need to establish correct budget allocation for this year. -Establish local cost code centres with the finance team. -On-going review of project business cases to ensure they are realistic and delivering on time. 2x4= 8 New CO5-04 Chief Officer & Medical Director Delivery of web enabled GP clinical IT systems is delayed due to lack of programme management which could impact the implementation of the PCS 4x4= 16 Regular meetings between Primary Care Strategy Manager & GP IT Manager Reporting to Primary Care Implementation Board -Internal Audit Review 3x4= 12 Lack of clear planning timetable and resource allocation Gap of Local presence from CSU IT Team and regular exception reporting Programme team to deliver a robust timetable and resource plan. IT Senior Programme Manager to attend the Primary Care Implementation Board. 2x4= 8 16
17 4.1. Governing Body Assurance Framework- Risk Profile Risk CO1-01 CO1-02 CO1-03 CO3-01 CO3-02 CO3-03 CO4-01 Risk description There is a that the CCG will not be able to invest sufficiently in services to reduce inequalities if it does not deliver its financial savings. This could lead to a failure to improve life expectancy Increased prevalence in long term conditions, high mortality rates relating to cancer and Cardiovascular Disease (CVD) In East Localities in comparison to the West Localities. Childhood obesity rates in the Borough are amongst one of the highest in the country and represent the seventh and twelfth highest rates in London respectively. There is a that the transfer of services under the BEH Clinical Strategy Programme may be affected by the commencement of a Judicial Review which could impact on the delivery of programme. Changes in the provider landscape which also includes the BEH Clinical Strategy could affect the Quality and Safety of patient care during transition. There is a that the Trust Development Agency (TDA) will not authorise BEH MHT to proceed to FT Status which could impact on service, business continuity and prolonged period of uncertainty. The CCG is at of not complying with its statutory responsibilities due to the lack of clarity on the arrangements in place for the following areas: Health & Safety, Fire, Security, Infection Control, Emergency Preparedness, Business Continuity, Compalints and Individual Funding Requests Initial Risk Rating APR QTR1 QTR2 QTR3 MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR Progress End of 2013/14 forecast Target Difference between forecast and target QTR4 17
18 CO4-02 CO4-03 CO4-04 CO4-05 CO4-06 CO4-07 CO 4-08 CO4-09 Risk of differing service scope expectations between CCG and CSU in first agreement year, due to the changing face of commissioning landscape. This may include business elements that are not yet in place / still to be set up affecting operational capability to deliver commissioning support services. Risk that the CCG will not achieve financial balance for the year 2013/14. this could lead to: reduced ability to achieve all corporate objectives, negative media coverage and reduced public support for the CCG There is a that Enfield CCG may not discharge the 7 conditions on Authorisation set by NHS England. This may result in negative media coverage and reduced public confidence. Insufficient QIPP Schemes may result to the CCG not meeting its 3 year QIPP Plan (this is also linked with acute contracts over perforrning) There is a that the CCG will be adversely affected by the impact of the transfer of Specialist Commissioning Services to NHS England which could impact on the CCG's financial position. Risk increased by additional reduction in 9 M from CCG allocation. There is a to the CCG if SLA s with major Acute, Mental Health and community Providers are not finalised and signed which could impact on the CCG s financial position and performance delivery. There is to the CCG if the cost of retrospective claims are not accurately assessed which could impact on the CCGs financial position. Access to SUS National data system is only available to ECCG for PCT closedown purposes for 12/13. Enfield CCG is not able to access patient data from the SUS system until national agreement is determined. This may cause delays to schemes incurring financial to performance and contract monitoring and accessing information for Enfield Transformation
19 CO 4-10 CO4-11 CO5-01 Acute Provider is unable to meet constitution target for waiting times- Referral to Treatment resulting in individuals waiting beyond the national standard. Barnet, Enfield & Haringey Mental Health Trust is unable to meet national target for increasing access to psychological therapies resulting in demands/supply with increased referrals t d i As the CCG no longer commissions Primary Care, there is a that some initiatives will be more complex to commission and the CCG will need additional support from NHS England & other bodies which may result in a potential delay in the implementation of the primary care Strategy CO5-02 CO5-03 Poor GP engagement, co-ordination of relevant teams and lack of defined outcome measures may result in not achieving goals of the Primary Care Strategy through networking arrangements. Risk that the budget allocated to Enfield for 2013/2014 will not be spent in full which could result in reduced capacity and expertise in delivering local health care with a consequential political impact CO5-04 Delivery of web enabled GP clinical IT systems is delayed due to lack of programme management which could impact the implementation of the PCS
20 5. Risk Grading Matrix Key L (Likelihood) x C (Consequence) = RR (Risk Rating) This is the grading matrix used to grade all Enfield CCG s. Red (15-25) Extreme Amber (8 12) High Yellow (4 6) Green (1-3) Moderate low 20
21 6. Appendix 1: How to interpret the Enfield CCG Board Assurance Framework This is the full Board Assurance Framework entry and has one line per Which Strategic objective is at? What is the s unique identifier? This is the in terms of: Likelihood x Severity With no mitigating controls in place. What documents provide evidence relating to the effectiveness of the control measures? E.g. Internal: Board reports External: NCB review This is the in terms of: Likelihood x Severity With mitigating factors in place. Summary of the plans to address the gaps in control / assurance and (Indicate target dates and action owners). Job title and initials of the lead(s). What could prevent the organisation from achieving this strategic objective? Consider: Patient harm, financial impact, reputation, etc as listed in the Integrated Risk Management Strategy. What can be done to reduce either: The likelihood of the occurring OR reducing the impact if it does occur? What additional controls and assurances are needed or could be added? This is the that the CCG would accept. What is within the CCG s appetite. 21
22 End 22
Risk Management Strategy
Risk Management Strategy Document Reference MLCSU CA_WL_V3 Version 3 Authors: Donna Bamber, Midlands & Lancashire Commissioning Support Unit Senior Risk Officer Smita Shetty, Service Redesign Manager,
More informationAppendix 4.1 MEETING: Haringey Clinical Commissioning Group Governing Body Meeting DATE: Thursday, 15 March 2018 TITLE: LEAD DIRECTOR: AUTHOR: CONTACT DETAILS: Operating Plan: Timetable and Governance
More informationRisk Management Strategy and Policy
Risk Management Strategy and Policy SUMMARY The purpose of this document is to provide guidance to all staff within the CCG on the management of strategic, operational and project risks within the organisation
More informationNHS North Central London Commissioning Strategy and QIPP Plan 2012/ /15
NHS North Central London Commissioning Strategy and QIPP Plan 2012/13-2014/15 Joint Health Overview and Scrutiny Committee 9 th July 2012 Sylvia Kennedy AD Strategy & Planning www.ncl.nhs.uk Key messages
More informationMEETING: Governing Body AGENDA ITEM: 6 DATE: 13 December 2018 TITLE: Governing Body Assurance Framework December 2018 AUTHOR:
MEETING: Governing Body AGENDA ITEM: 6 DATE: 13 December 2018 TITLE: Governing Body Assurance Framework December 2018 AUTHOR: Russell Carpenter, Head of Governance/Board Secretary LEAD DIRECTOR: Robert
More informationNHS Planning Guidance 2016/ /21
NHS Planning Guidance 2016/17 2020/21 Trust Board Meeting Item: 13 Date: 27 th January 2016 Purpose of the Report: Enclosure: I1 To provide the Board with a summary of the NHS Annual Planning Guidance
More information2018/19 Planning, Commissioning Intentions and Governing Body Assurance Framework
2018/19 Planning, Commissioning Intentions and Governing Body Assurance Framework Governing Body meeting 11 January 2018 G Author(s) Sponsor Director Purpose of Paper Abigail Tebbs, Deputy Director of
More informationAppendix:6.2 MEETING: Paul Sinden Director of Commissioning CONTACT AUTHOR: DETAILS: SUMMARY:
Appendix:6.2 MEETING: Islington Clinical Commissioning Group Governing Body DATE: Wednesday 6 May 2015 TITLE: Strategy and Finance Committee Update for May 2015 LEAD GOVERNING Dr. Jo Sauvage Clinical Vice
More informationAgenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET
Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET DATE: 9 th August 2016 TITLE OF PAPER: Financial Position- Month 3 EXECUTIVE RESPONSIBLE: Laura Boden - Acting Chief Finance Officer Ext:2483 Email: lboden@nhs.net
More informationRISK MANAGEMENT ANNUAL REPORT 2016/2017
RISK MANAGEMENT ANNUAL REPORT 2016/2017 Lead Executive Director Dr Iain Wallace, Medical Director Report Prepared By Mrs Carol McGhee, Corporate Risk Manager Approved By Corporate Management Team May 2017
More informationIntegrated Risk Management Framework
Integrated Risk Management Framework Author Patient Safety Manager Version 4.0 Version Date May 2017 Implementation/Approval Date May 2017 Review Date May 2018 Review Body Governing Body Policy Reference
More informationSHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY D REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018 Subject: NHS Planning Guidance 2018-19 Supporting TEG Member: Authors: Status Neil
More informationINTEGRATED RISK MANAGEMENT FRAMEWORK (STRATEGY AND POLICY)
INTEGRATED RISK MANAGEMENT FRAMEWORK (STRATEGY AND POLICY) Version 1.5 (DRAFT) RATIFIED DATE BY WHOM Fylde and Wyre CCG Governing Body Fylde and Wyre CCG (F&W CCG) is committed to ensuring that, as far
More informationManchester Health and Care Commissioning. Finance Committee. Terms of Reference
Manchester Health and Care Commissioning Finance Committee Terms of Reference 1.0 Name The Committee shall be known as the Finance Committee. 2.0 Overview The Finance Committee forms a key element of the
More informationPolicy and Resources Committee 21 March 2017
Policy and Resources Committee 21 March 2017 Title Future of Barnet Public Health Service Report of Wards Status Urgent Key Enclosures Officer contact details Dawn Wakeling, Adults and Health Commissioning
More informationBNSSG CCG Governing Body Meeting
BNSSG CCG Governing Body Meeting Date: Tuesday 5 th February 2019 Time: 1.30pm Location: The Royal Hotel, 1 South Parade, Weston-super-Mare BS23 1JP Agenda number: 8.2 Report title: BNSSG CCG Finance Report
More informationRISK MANAGEMENT ANNUAL REPORT
ITEM 15B RISK MANAGEMENT ANNUAL REPORT 2017/2018 Lead Executive Director Report Prepared By Mr Calum Campbell, Chief Executive Mrs Carol McGhee, Corporate Risk Manager Approved By Corporate Management
More informationRISK MANAGEMENT STRATEGY Version 3
RISK MANAGEMENT STRATEGY Version 3 Risk Management Strategy V3 - March 2018 1 Standard Operating Procedure St Helens CCG Risk Management Strategy Version 3.0 Implementation Date September 2014 Review Date
More informationSolent NHS Trust Shadow Historical Due Diligence Paper for Trust Board June 2011
Solent NHS Trust Shadow Historical Due Diligence Paper for Trust Board June 2011 Summary This paper sets out the programme for shadow due diligence in July. Board members are asked to note the timetable,
More informationDiscussion. Information
Item 10.8 To: From: Trust Board Kevin Turner, Deputy Chief Executive Date: 4 th July 2017 Title: Strategic Risk Management Report Responsible Director: Kevin Turner, Deputy Chief Executive Author: Karen
More informationNHS North Somerset Clinical Commissioning Group Risk Management Strategy and Framework
NHS North Somerset Clinical Commissioning Group Risk Management Strategy and Framework An Integrated Risk Management Framework Clinical Risk Management Financial Risk Management Corporate Risk Management
More informationRISK REGISTER POLICY AND PROCEDURE
RISK REGISTER POLICY AND PROCEDURE Lead Manager: Head of Clinical Governance Responsible Director: Board Medical Director Approved by: Date Approved: Date for Review: Feb 2012 Replaces Version: 1.0 Page
More informationIntegrated Risk Management Framework Sept Page 1 of 17
Integrated Risk Management Framework 2017-2018 Sept 2017 Page 1 of 17 Reference: Title: Author/Nominated Lead: Approval Date: Approving Committee: Review Date: Target Audience: Circulation List: Cross
More informationNLG(18)407. DATE OF MEETING 27 November Trust Board of Directors Public. Wendy Booth, Trust Secretary
NLG(18)407 DATE OF MEETING 27 November 2018 REPORT FOR Trust Board of s Public REPORT FROM Wendy Booth, Trust Secretary CONTACT OFFICER Jeremy Daws, Head of Quality Assurance Kelly Burcham, Head of SUBJECT
More informationGOVERNING BODY NOTES OF THE FINANCE SUB COMMITTEE HELD ON TUESDAY 25 MARCH 2014 GROVES MEDICAL CENTRE, NEW MALDEN
GOVERNING BODY LEAD: Finance Committee Chair ATTACHMENT: M1 ACTION: For Information NOTES OF THE FINANCE SUB COMMITTEE HELD ON TUESDAY 25 MARCH 2014 GROVES MEDICAL CENTRE, NEW MALDEN PRESENT: Paul Gallagher
More information2017/18 Quality, Innovation, Productivity and Prevention Programme
2017/18 Quality, Innovation, Productivity and Prevention Programme Governing Body meeting 5 October 2017 Item 3 Author(s) Abby Tebbs, Deputy Director of Strategic Commissioning and ning Julia Newton, Director
More informationREPORT TO BOARD. 10 th June Agenda No St George s University Hospital Foundation Trust Review
Attach 12 REPORT TO BOARD 10 th June 2015 Agenda No. 8.1 Title of Document: St George s University Hospital Foundation Trust Review Report Author: Lead Director/ Clinical Lead: Contact details: Hardev
More informationGOVERNING BODY. 2. To ensure the CCG financial position recovers to meet all statutory financial duties. X
Enclosure: H Agenda item: 10 GOVERNING BODY Title of paper: QIPP Report Date of meeting: 21st September 2016 Presented by: Regina Shakespeare Prepared by: Regina Shakespeare and Nick Varney Title: Turnaround
More informationRisk Management Policy and Strategy
Risk Management Policy and Strategy Version: 2.1 Bodies consulted: Approved by: Directors and Managers responsible for risk Board of Directors Date Approved: 28 March 2017 Lead Manager: Lead Director:
More informationKingston Clinical Commissioning Group Report Summary
Kingston Clinical Commissioning Group Report Summary Meeting Title Governing Body in public Date 7 th November 2017 Report Title Finance Committee Minutes Agenda Item 15 Attachment O1 Purpose (please indicate
More informationBOARD ASSURANCE FRAMEWORK BoD 44/14
BOARD ASSURANCE FRAMEWORK: OVERVIEW Definitions: Risk: this shows the current risk status as agreed with the Executive lead. Where there is more than one risk this is aggregated to form one score. Performance:
More informationThemed Audit Schools Budget Setting, Management and Control
Internal Audit Report Themed Audit Schools Budget Setting, Management and Control 2015/16 Issued to: Copied to Simon Newland Assistant Director (Education Provision and Access) Marcus Cooper Senior Education
More informationBUDGET SETTING PRINCIPLES
MEETING DATE: 11 December 2014 AGENDA ITEM NUMBER: Item 7.2 AUTHOR: JOB TITLE: DEPARTMENT: Therese Paskell Chief Finance Officer & Business Support CCG REPORT TO THE CLINICAL COMMISSIONING GROUP GOVERNING
More informationRisk Management Strategy
Risk Management Strategy 2016 2019 Version: 6 Policy Lead/Author & Deputy Director of Quality position: Ward / Department: Nursing Directorate Replacing Document: Version 5 Approving Committee Quality
More information2.2. CCG Board Meeting Paper Summary Sheet. Agenda Item. DETAILS Part 1 (Open) X Part 2 (Closed) Title of Paper Board Annual Cycle of Business Meeting
CCG Board Meeting Paper Summary Sheet DETAILS Part 1 (Open) X Part 2 (Closed) Title of Paper Board Annual Cycle of Business Meeting Board Meeting Date 3 rd September 2015 Executive Lead Dr Ian Orpen, Chair
More informationPaper Finance Report. Month 11 (February 2016)
Paper 12.0 Finance Report Month 11 (February 2016) Finance Report Month 11 (February 2016) Index Slide Executive Summary 2 Summary Financial Position 3 Key Variances 5 Reserves 7 Risks and Opportunities
More informationFinancial Summary of the Barnet and Chase Farm Hospital merger with the Royal Free NHS Hospital Foundation Trust
Financial Summary of the Barnet and Chase Farm Hospital merger with the Royal Free NHS Hospital Foundation Trust 1. Context and Purpose The purpose of this paper is to provide an update on the financial
More informationRisk Management Policy
Version: 2.0 New or Replacement: Policy number: Document author(s): Replacement ULHT-MD-GOV-RM-PMIMSI Paul White, Risk Manager Contributor(s): Members of the Trust Board & Senior Leadership Team Approved
More informationCroydon Integrated Governance and Audit Committee. Minutes
Attachment 01 Croydon Integrated Governance and Audit Committee Minutes Date: Tuesday 20 June, 2013 Time: 9.30-11.30 a.m. Location: Masonic Hall Croydon Present: Members: Helen Pernelet, Lay Member and
More informationThe Annual Audit Letter for Chorley and South Ribble Clinical Commissioning Group
The Annual Audit Letter for Chorley and South Ribble Clinical Commissioning Group Year ended 31 March 2016 June 2016 Fiona Blatcher Engagement Lead T 0161 234 6393 E fiona.c.blatcher@uk.gt.com Gareth Winstanley
More informationAnnual Audit Letter Year ending 31 March NHS West Lancashire CCG 22 June 2018
Annual Audit Letter Year ending 31 March 2018 NHS West Lancashire CCG 22 June 2018 Contents Section Page 1. Executive summary 3 2. Audit of the accounts 4 3. Value for Money arrangements 7 Your key Grant
More informationRisk Management Strategy
Risk Management Strategy Job title of lead contact: Corporate Services Manager Version number: Version 1 Group responsible for approving Executive Team / Governing Body the document: Date of final approval:
More informationUNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Activity Management Monitoring
UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST Activity Management Monitoring Report to: Trust Board - 29 th November 2011 Report from: Sponsoring Executive: Aim of Report/ Principle Topic: Review
More informationLONDON BOROUGH OF ENFIELD RISK MANAGEMENT STRATEGY
LONDON BOROUGH OF ENFIELD RISK MANAGEMENT STRATEGY JANUARY 2013 1 Version Control Reference Comments Approval date 05 09 12 19 11 12 10 01 13 2 FOREWORD Welcome to the Council s Risk Management Strategy.
More informationTITLE OF REPORT: QIPP Programme Update Month 7. Kelly Knowles Head of Strategic Financial Planning. Annette Walker Chief Finance Officer
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 13 Date of Meeting: 25 th November 2016 TITLE OF REPORT: QIPP Programme Update Month 7 AUTHOR: PRESENTED BY: PURPOSE OF PAPER:
More information2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval
Agenda Item: 13 NHS Norwich CCG Governing Body Tuesday 28 th March 2017 Subject: Presented By: 2017/18 Financial Plan and Budgets John Ingham, Chief Finance Officer, NHS Norwich CCG Submitted To: NHS Norwich
More information2017/19 Draft Operating Plan Update
2017/19 Draft Operating Plan Update This paper is for: Information Recommendation: The Governing Body is requested to note the progress on production of the 2017/19 Draft Operating Plan. For further information
More information3 February 2016 Enclosure H1
Report to Trust Board (in public) Title Finance & Performance Committee Chairman Report Sponsoring Director F & P Committee Chairman / Non-Executive Director Author Haq Khan Deputy Director of Finance
More informationINTEGRATED RISK MANAGEMENT FRAMEWORK
INTEGRATED RISK MANAGEMENT FRAMEWORK 2018 20 VERSION Version Date Author Status Comment Draft 1 29.5.2014 Draft 2 10.6.2014 Richard Walker & Vicky Peverelle Richard Walker & Vicky Peverelle Draft Draft
More informationFinance and QIPP (Quality, Innovation, Productivity & Prevention) Plan 2015/16 John Ingham, Chief Financial Officer
Agenda Item: 11.2 Subject: Presented by: Finance and QIPP (Quality, Innovation, Productivity & Prevention) Plan 2015/16 John Ingham, Chief Financial Officer Submitted to: NHS West Norfolk CCG Governing
More informationBOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000
BOARD OF DIRECTORS COVER SHEET PART 1 DATE: 3 January 219 Agenda item: 11 Paper: F Subject: CHARITABLE FUNDS EXPENDITURE OVER 25, Prepared by: Presented by: Purpose of paper Background Key points for Board
More informationRisk Management Framework
Risk Management Framework Introduction The outgoing Corporate Strategy 2013-18 and incoming University Strategy 2018-23 continues on a trajectory towards Vision 2025 in an increasingly competitive Higher
More informationRisk Assessment and Risk Register
Standard Operational Procedure 1 (SOP 1) Risk Assessment and Risk Register Why we have a procedure? Effective risk management processes enable the Trust to ensure actions are taken to identify areas of
More informationTo: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard:
Paper C To: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard: C7 a&c Title: Better For Less: Financial Planning
More informationPaper Finance Report. Month 9 (December 2015)
Paper 16.0 Finance Report Month 9 (December 2015) Finance Report Month 9 (December 2015) Index Slide Executive Summary 2 Summary Financial Position 3 Key Variances 5 Reserves 7 Risks and Opportunities
More informationChief Finance Officer. The CCG reports a surplus of 79k for the year after holding a projected a surplus of 32k for the last three months.
Agenda item 8 TITLE PRESENTED BY LEAD MANAGER PURPOSE OF PAPER RECOMMENDATION EQUALITY & DIVERSITY IMPACT FINANCE REPORT Stephen Schofield Chief Finance Officer Stephen Schofield Chief Finance Officer
More informationCommissioning for Quality and Innovation (CQUIN) Guidance for
Commissioning for Quality and Innovation (CQUIN) Guidance for 2017-2019 Publications Gateway Reference 06023 November 2016 Contents Section Slide 1.0 Introduction 2 2.0 Clinical quality and transformational
More informationIntegrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014
Integrated Quality, Performance and Finance Reporting Framework Reporting period: Month 9 December 2014 Contents Section Page Trust Scorecard 3 Trust Heatmap 5 Scorecard matrix 6 Areas of underperformance
More informationBoard of Directors Meeting Report 25 May Agenda item 49/16
Board of Directors Meeting Report 25 May 2016 Agenda item 49/16 Title Sponsoring Director Author(s) Financial Position James O Sullivan Chief Financial Officer Adrian Buggle Deputy Director of Finance
More informationHSCIC Financial Management and Reporting
HSCIC Financial Management and Reporting Author: Rebecca Giles/Carl Vincent Date 24 th February 2014 1 Copyright 2014, Health and Social Care Information Centre. Contents Contents 2 Introduction 3 Current
More informationRisk Management Procedure. Version Number: 6.0 Controlled Document Sponsor: Controlled Document Lead:
Risk Management Procedure CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Procedure Governance To detail the procedure for the management of risk 419 Version Number: 6.0
More informationNHS SOUTH LINCOLNSHIRE CLINICAL COMMISSIONING GROUP AUDIT & RISK COMMITTEE TERMS OF REFERENCE
Appendix I NHS SOUTH LINCOLNSHIRE CLINICAL COMMISSIONING GROUP 1. GOVERNANCE NOTE AUDIT & RISK COMMITTEE TERMS OF REFERENCE South Lincolnshire and South West Lincolnshire CCGs have each established their
More informationMonth 10 Finance Report
TAUNTON & SOMERSET NHS FOUNDATION TRUST Month 10 Finance Report Report to: Trust Board on 24 February 2016 Purpose of the Report: The purpose of the report is to update the Board on the Month 10 financial
More informationRisk Management Strategy January NHS Education for Scotland RISK MANAGEMENT STRATEGY
NHS Education for Scotland RISK MANAGEMENT STRATEGY January 2016 1 Contents 1. NES STATEMENT ON RISK MANAGEMENT 2 RISK MANAGEMENT STRATEGY 3 RISK MANAGEMENT STRUCTURES 4 RISK MANAGEMENT PROCESSES 5 RISK
More informationNHS VALE OF YORK CLINICAL COMMISSIONING GROUP
Item 17 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP Minutes of the meeting of the Audit Committee held on 19 April 2013 at St Catherine s Hospice, Scarborough Present Mr Keith Ramsay (Chair) Lay Member
More informationhealthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning.
GOVERNING BODY Title of paper: Finance Update Month 4 Date of meeting: 5 th September 2018 Presented by: David Maloney Title: Chief Finance Officer & email contact: D.Maloney@nhs.net Prepared by: Nick
More informationCommissioning for Quality and Innovation (CQUIN)
Commissioning for Quality and Innovation (CQUIN) Guidance for 2017-2019 Publications Gateway Reference 07725 March 2018 www.england.nhs.uk Contents Section Slide 1.0 Introduction 3 2.0 Clinical quality
More informationMerton CCG Balanced Scorecard Reporting period: Q1 NHSE Q2 NHSE Q3 (CCG Rating)
Merton CCG Balanced Scorecard Reporting period: Q1 NHSE Q2 NHSE Q3 (CCG Rating) re local people getting good quality care? mber/green mber/green mber/green re patient rights under the NHS Constitution
More informationTrust Assurance Framework Reviews. (Structure, Engagement and Alignment 2017/18)
Trust Assurance Framework Reviews (Structure, Engagement and Alignment 217/18) The overall purpose of the insight is to summarise the results of the 217/18 Assurance Framework reviews, highlight good practice
More informationMedicine Management NELCSU Document
For inclusion in NHS Provider contracts as a document relied on: CCG Commissioned National Tariff Payment System (NTPS) Formerly Payment by Results Excluded Drugs & Devices Policy 2017/19 Amendment history:
More informationNHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 24 April 2018
Part 1 Part 2 NHS TRAFFORD CLINICAL COMMISSIONING GROUP GOVERNING BODY 24 April 2018 Title of report Finance Report for 12 months 2017/18 Purpose of the report and key highlights To provide members with
More informationAPPENDIX I: Corporate Risk Register
APPENDIX I: Corporate Register The following risk register represents those risks in place at the time of reporting at Quarter 1, the mitigation strategies in place for each risk and the proposed treatment
More informationCroydon Borough Team Integrated Governance and Audit Committee. Minutes. Paula Swann, (PS) Croydon Borough Amy Page (AP), Chief Nurse, Croydon CCG
Attachment E3 Croydon Borough Team Integrated Governance and Audit Committee Date: Thursday 13 December 2012 Time: 10 12 p.m. Location: Room 11.4 Leon House Minutes Present: In Attendance: Members: Maureen
More informationThe Annual Audit Letter for Royal National Orthopaedic Hospital NHS Trust
The Annual Audit Letter for Royal National Orthopaedic Hospital NHS Trust Year ended 31 March 2016 26 July 2016 Iain G Murray Engagement Lead T 020 7728 3328 E Iain.G.Murray@uk.gt.com James Thirgood Engagement
More informationTAMESIDE AND GLOSSOP SINGLE COMMISSIONING BOARD. 11 April 2017
TAMESIDE AND GLOSSOP SINGLE COMMISSIONING BOARD 11 April 2017 Commenced: 3.00 pm Terminated: 4.20 pm PRESENT: IN ATTENDANCE: Alan Dow (Chair) Tameside and Glossop CCG Steven Pleasant Tameside Council Chief
More informationCorporate Performance Report 2015/16
Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close
More informationRisk Management Strategy
Resources Risk Management Strategy Successful organisations are not afraid to take risks; Unsuccessful organisations take risks without understanding them. Issue: Version 3 - November 2011 Group: Resources
More informationBOARD ASSURANCE FRAMEWORK & SIGNIFICANT RISK REGISTER Trust Board in public
BOARD ASSURANCE FRAMEWORK & SIGNIFICANT RISK REGISTER Trust Board in public Date: 22 February 2018 Agenda item: 1.7 Executive sponsor Report author(s) Report discussed previously: (name of sub-committee/group
More informationNHS Standard Contracts 2017/ /19
NHS Standard Contracts 2017/18 2018/19 Video presentation for commissioners and providers (available on the NHS England YouTube channel) Presentation 3 of 3 Contract management NHS Standard Contract Team
More informationMERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY
MERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY Date of Meeting: 30 th November 2017 Agenda No: 9.2 Attachment: 11 Title of Document: Finance Report Month 7 Report Author: Robert Kirton Purpose of Report:
More informationAttachment D1. Month 6 QIPP Report. 1 Background
Attachment D1 Month 6 QIPP Report 1 Background 1.1 The South West London (SWL) Quality, Innovation, Productivity and Prevention (QIPP) plans are set in a context of an environment in which complex issues
More informationReport to the Sutton Clinical Commissioning Group Board
Sutton and Merton Borough Teams Sutton Clinical Commissioning Group Report to the Sutton Clinical Commissioning Group Board Date of Meeting: Wednesday, 3 rd April 2013 Agenda No: 6.1 Attachment: 06 Title
More informationReport to the Merton Clinical Commissioning Group Governing Body
MCCG Bd 24.01.13 Pt1 :6.1 : Att 03 Merton Clinical Commissioning Group Report to the Merton Clinical Commissioning Group Governing Body Date of Meeting: Thursday 24 th January 2013 Agenda No: 6.1 ATTACHMENT
More informationPaper 5b. PMS Contract Reviews.
Paper 5b PMS Contract Reviews 18 August 2015 PMS Contract Reviews In February 2014 Area Teams received guidance setting out a requirement to review all PMS contracts by March 2016. The purpose of the review
More informationRisk Management & Assurance Strategy. Audit Committee. See reference page 38
BHH Brent Harrow Hillingdon Clinical Commissioning Groups Risk Management & Strategy Author: Policy Number: Version: Sponsor/Executive: Responsible committee: Gilbert George Dawn Crump Interim Head of
More informationReport. Chris Ford Joint Chief Finance Officer
Governing Body Meeting held in public Report Date of Meeting: 8 November 2018 Agenda Item: 15.0 Report Title Finance Report as at 30 th September 2018 (Month 6) Report Author Presented By Responsible Director
More informationThis report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017.
Finance & Contracting Performance Report: Period ended 31 March 2017 Introduction This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017. 1 Revenue
More informationInternal Audit Report
Internal Audit Report Health and Safety - Estates February 2017 To: Acting Chief Operating Officer Director of Resources Head of Estates Head of Safety, Health and Wellbeing Partnership Director, CSG Operations
More informationHSC Business Services Organisation Board
Paper BSO 25/2009 HSC Business Services Organisation Board Risk Management 1. Purpose of this report The purpose of this report is to brief the Board on the BSO Risk Management process. 2. Background HSC
More informationThe Annual Audit Letter for NHS Croydon Clinical Commissioning Group
The Annual Audit Letter for NHS Croydon Clinical Commissioning Group Year ended 31 March 2016 July 2016 Sarah Ironmonger Engagement Lead T 01293 554 072 E Sarah.L.Ironmonger@uk.gt.com Matt Dean Engagement
More informationOperational Performance. SaTH Overall Performance
Balanced Scorecard Summary Operational Performance Previous This Year to Date Previous This Year to Date Number Number Number Number Number Green 17 17 15 Green 7 7 0 Amber 3 2 2 Amber 1 0 0 Red 2 4 5
More informationThe Royal Wolverhampton NHS Trust
The Royal Wolverhampton NHS Trust Trust Board Meeting Date: 25 April 2016 Title: Income and Expenditure Plan for 2016/17 Executive Summary: Action Requested: This report details the proposed Income & Expenditure
More informationThe Annual Audit Letter for Oldham Metropolitan Borough Council
The Annual Audit Letter for Oldham Metropolitan Borough Council Year ended 31 March 2016 24 October 2016 Graham Nunns Engagement Lead T 0113 200 2538 E grahm.nunns@uk.gt.com Marianne Dixon Manager T 0113
More informationUNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST AUDIT COMMITTEE ANNUAL REPORT 2011/2012
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST AUDIT COMMITTEE ANNUAL REPORT 2011/2012 UCL Hospitals is an NHS Foundation Trust comprising: The Eastman Dental Hospital, The Heart Hospital, Hospital
More informationWest Hertfordshire Hospitals NHS Trust. Finance Report. Period 12. April to March 2009
West Hertfordshire Hospitals NHS Trust Finance Report Period 12 April to March 2009 Presented by Phil Bradley (Acting) Director of Finance 17 April 2009 1 Summary Financial Overview as at 31 March 2009
More informationCumbria Local Enterprise Partnership CENTRAL ASSURANCE FRAMEWORK
Cumbria Local Enterprise Partnership CENTRAL ASSURANCE FRAMEWORK February 2017 PART ONE: LEP GOVERNANCE AND DECISION MAKING 1.1 Name The purpose of the Cumbria LEP Central Assurance Framework is to put
More informationCIoS System Strategic Estates Group Briefing
CIoS System Strategic Estates Group Briefing Transformation Board 17/01/2019 Jackie Pendleton, Chief Executive Lead Karl Simkins, CIoS Chief Finance Officer & Estates SRO Final Strategic Estates Group
More informationAGENDA ITEM: 10 Page nos Fitness for Life scheme (Instructor-led walks)
AGENDA ITEM: 10 Page nos. 20-24 Meeting General Functions Committee Date 14 January 2009 Subject Report of Summary Fitness for Life scheme (Instructor-led walks) Director for Resources This reports deals
More informationDATE: 14 th October 2016 Primary Care Co-Commissioning Due Diligence LEAD COMMITTEE MEMBER: Ahmet Koray, Chief Finance Officer (Islington CCG)
APPENDIX B OUTLINE DUE DILIGENCE INFORMATION DATE: 14 th October 2016 TITLE: Primary Care Co-Commissioning Due Diligence LEAD COMMITTEE MEMBER: Ahmet Koray, Chief Finance Officer (Islington ) AUTHOR: Daniel
More informationNHS Wandsworth Finance Report. For the period April 2012 November 2012 & Interim Report up to December 2012
NHS Wandsworth Finance Report For the period April 2012 November 2012 & Interim Report up to December 2012 06/02/2013 Produced by Finance 1 Finance Scorecard up to November 2012 Financial Strategy Work
More information